Cargando…

The First Case of Ischemia-Free Kidney Transplantation in Humans

Background: Ischemia-reperfusion injury (IRI) has been considered an inevitable event in organ transplantation since the first successful kidney transplant was performed in 1954. To avoid IRI, we have established a novel procedure called ischemia-free organ transplantation. Here, we describe the fir...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xiaoshun, Chen, Guodong, Zhu, Zebin, Zhang, Zhiheng, Yuan, Xiaopeng, Han, Ming, Zhao, Qiang, Zheng, Yitao, Tang, Yunhua, Huang, Shanzhou, Wang, Linhe, van Leeuwen, Otto B., Wang, Xiaoping, Chen, Chuanbao, Mo, Liqiu, Jiao, Xingyuan, Li, Xianchang, Wang, Changxi, Huang, Jiefu, Cui, Jun, Guo, Zhiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6917615/
https://www.ncbi.nlm.nih.gov/pubmed/31921864
http://dx.doi.org/10.3389/fmed.2019.00276
Descripción
Sumario:Background: Ischemia-reperfusion injury (IRI) has been considered an inevitable event in organ transplantation since the first successful kidney transplant was performed in 1954. To avoid IRI, we have established a novel procedure called ischemia-free organ transplantation. Here, we describe the first case of ischemia-free kidney transplantation (IFKT). Materials and Methods: The kidney graft was donated by a 19-year-old brain-dead donor. The recipient was a 47-year-old man with end-stage diabetic nephropathy. The graft was procured, preserved, and implanted without cessation of blood supply using normothermic machine perfusion. Results: The graft appearance, perfusion flow, and urine production suggested that the kidney was functioning well-during the whole procedure. The creatinine dropped rapidly to normal range within 3 days post-transplantation. The levels of serum renal injury markers were low post-transplantation. No rejection or vascular or infectious complications occurred. The patient had an uneventful recovery. Conclusion: This paper marks the first case of IFKT in humans. This innovation may offer a unique solution to optimizing transplant outcomes in kidney transplantation.